NCPIC - National Cannabis Prevention and Information Centre

Publications Bulletin - January 2010

Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

  • Dekker, N., Schmitz, N., Peters, B.D., van Amelsvoort, T.A., Linszen, D.H., & de Haan, L. (2010). Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Research 181, 51-56.
  • Grant, J.D., Lynskey, M.T., Scherrer, J.F., Agrawal, A., Heath, A.C., & Bucholz, K.K. (2010). A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use. Addictive Behaviors 35, 35-41.
  • Hancox, R.J., Poulton, R., Ely, M., Welch, D., Taylor, D.R., McLachlan, C.R., Greene, J.M., Moffitt, T.E., Caspi, A., & Sears, M.R. (2010). Effects of cannabis on lung function: A population-based cohort study. European Respiratory Journal 35, 42-47.
  • Jayanthi, S., Buie, S., Moore, S., Herning, R.I., Better, W., Wilson, N.M., Contoreggi, C., & Cadet, J.L. (2010). Heavy marijuana users show increased serum apolipoprotein C-III levels: Evidence from proteomic analyses. Molecular Psychiatry 15, 101-112.
  • Katz, G., Durst, R., Shufman, E., Bar-Hamburger, R., & Grunhaus, L. (2010). Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients. Comprehensive Psychiatry 51, 37-41.
  • Kelly, B.D., O'Callaghan, E., Waddington, J.L., Feeney, L., Browne, S., Scully, P.J., Clarke, M., Quinn, J.F., McTigue, O., Morgan, M.G., Kinsella, A., & Larkin, C. (2010). Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland. Schizophrenia Research 116, 75-89.
  • McLaren, J.A., Silins, E., Hutchinson, D., Mattick, R.P., & Hall, W. (2010). Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. International Journal on Drug Policy 21, 10-19.
  • Nestor, L., Hester, R. & Garavan, H. (2010). Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. Neuroimage 49, 1133-1143.
  • Richardson, T. & Gallagher, A. (2010). Comment on Hides et al. - Cannabis use and psychotic-like experiences. Schizophrenia Research 116, 98.
  • Selvarajah, D., Gandhi, R., Emery, C.J., & Tesfaye, S. (2010). Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: Depression is a major confounding factor. Diabetes Care 33, 128-130.
  • Simons-Morton, B., Pickett, W., Boyce, W., ter Bogt, T.F., & Vollebergh, W. (2010). Cross-national comparison of adolescent drinking and cannabis use in the United States, Canada, and the Netherlands. International Journal on Drug Policy 21, 64-69.
  • Spano, M.S., Fadda, P., Frau, R., Fattore, L., & Fratta, W. (2010). Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats. European Neuropsychopharmacology 20, 25-36.
  • Tashkin, D.P. (2010). Does cannabis use predispose to chronic airflow obstruction? European Respiratory Journal 35, 3-5.